colchicine · Scilex Pharms · NDA 210942
Gloperba
Earliest generic entry, as listed
20 Dec 2037
Blocked by patent: US 10226423.
Listed patents · 6 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10226423 | product | 20 Dec 2037 |
| US 10383820 | product, use U-2814 | 22 Nov 2036 |
| US 10383821 | product | 22 Nov 2036 |
| US 12274751 | use U-2814 | 22 Nov 2036 |
| US 12514819 | use U-2814 | 22 Nov 2036 |
| US 9907751 | product | 22 Nov 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210942 · 001 · RLD | solution, oral | 0.6MG/5ML | 20 Dec 2037 |